Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1033 | 1016 | 1034 | 1054 | 1271 | 1903 |
Fund Return | 3.26% | 1.64% | 3.35% | 1.77% | 4.92% | 6.65% |
Place in category | - | - | - | - | - | - |
% in Category | 86 | 96 | 91 | 80 | 65 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth CAD | 4.22B | 5.68 | 6.11 | 9.92 | ||
Renaissance Global Growth Cl F CAD | 4.22B | 6.14 | 7.49 | 11.37 | ||
Renaissance International Eq Cl CAD | 1.81B | 3.71 | 3.10 | 8.10 | ||
Renaissance US Equity Income F CAD | 1.41B | 6.77 | 7.73 | 10.34 | ||
Renaissance US Eq Income F Pr CAD | 1.41B | 6.79 | 7.79 | 10.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mawer International Equity Fund Cla | 7.61B | 6.04 | 1.84 | 6.78 | ||
DFA International Core Equity Class | 3.05B | 6.00 | 4.49 | 6.37 | ||
RBC International Equity Fund D CAD | 2.38B | 7.29 | 4.34 | 7.39 | ||
RBC International Equity Sr F CAD | 2.38B | 7.39 | 4.63 | 7.67 | ||
Sun Life MFS Intl Value A T5 | 2.17B | 8.18 | 2.01 | 7.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.35 | 917.1 | +0.78% | |
ASML Holding | NL0010273215 | 3.64 | 851.00 | +1.23% | |
Keyence | JP3236200006 | 3.02 | 70,550.0 | -0.72% | |
Taiwan Semiconductor | US8740391003 | 2.93 | 155.55 | +2.37% | |
Experian | GB00B19NLV48 | 2.68 | 3,752.0 | +8.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review